R22
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 91
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- CHOLESTEROL_HOMEOSTASIS+0.340
- MYOGENESIS+0.230
- WNT_BETA_CATENIN_SIGNALING+0.180
- MYC_TARGETS_V2+0.170
- UV_RESPONSE_UP+0.150
- DNA_REPAIR+0.140
- P53_PATHWAY+0.110
- ESTROGEN_RESPONSE_EARLY+0.100
- XENOBIOTIC_METABOLISM+0.100
- APICAL_SURFACE+0.060
Top 10 suppressed
- ALLOGRAFT_REJECTION-0.440
- INTERFERON_GAMMA_RESPONSE-0.440
- IL6_JAK_STAT3_SIGNALING-0.390
- INTERFERON_ALPHA_RESPONSE-0.390
- INFLAMMATORY_RESPONSE-0.360
- PROTEIN_SECRETION-0.360
- UV_RESPONSE_DN-0.360
- COMPLEMENT-0.260
- KRAS_SIGNALING_UP-0.260
- PI3K_AKT_MTOR_SIGNALING-0.260
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | R45 | — | — | 0.840 |
| 2 | SJEPD037_D.RNA-Seq | EPN | Posterior Fossa EPN | 0.821 |
| 3 | R100 | — | — | 0.805 |
| 4 | SRR25617832 | — | B | 0.802 |
| 5 | TCGA-EW-A424-01A-11R-A24H-07 | — | B | 0.787 |
| 6 | MNG857 | — | — | 0.786 |
| 7 | 4f521ce8-4aac-4ea5-abbe-732ff9ac5409 | — | — | 0.786 |
| 8 | 3e1c728a-cf38-4ca8-9d87-0bbf098567a6 | — | — | 0.784 |
| 9 | SRR25043618 | — | — | 0.781 |
| 10 | 85d43afd-9aac-48ca-a9c4-00357b7207e1 | — | — | 0.765 |